Bioventix (LSE:BVXP) Inventories, Finished Goods : £0.00 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Bioventix Inventories, Finished Goods?

Bioventix's quarterly finished goods increased from Dec. 2022 (£0.00 Mil) to Jun. 2023 (£0.57 Mil) but then declined from Jun. 2023 (£0.57 Mil) to Dec. 2023 (£0.00 Mil).

Bioventix's annual finished goods increased from Jun. 2021 (£0.33 Mil) to Jun. 2022 (£0.46 Mil) and increased from Jun. 2022 (£0.46 Mil) to Jun. 2023 (£0.57 Mil).

Bioventix Inventories, Finished Goods Historical Data

The historical data trend for Bioventix's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Inventories, Finished Goods Chart

Bioventix Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.24

0.25

0.33

0.46

0.57

Bioventix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															-	0.46	-	0.57	-

Bioventix Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Bioventix (LSE:BVXP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

BVXP.GB:UK 51B:Germany

Address

East Street, 7 Romans Business Park, Farnham, Surrey, GBR, GU9 7SX

Website

http://www.bioventix.com

Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.

Bioventix (LSE:BVXP) Headlines

No Headlines